CT

Cyclerion Therapeutics

CYCN
NASDAQHealth Care

Insider Trades

cycn
over 1 year ago

Slate Path Capital LP sold 357,880 shares of CYCN on 21 November. They now own 0 CYCN shares, or a 100% holding decrease.

Slate Path Capital LP sold CYCN